A New KIT Mutation (N505I) in Acral Melanoma Confers Constitutive Signaling, Favors Tumorigenic Properties, and Is Sensitive to Imatinib - Archive ouverte HAL Access content directly
Journal Articles Journal of Investigative Dermatology Year : 2014

A New KIT Mutation (N505I) in Acral Melanoma Confers Constitutive Signaling, Favors Tumorigenic Properties, and Is Sensitive to Imatinib

(1) , (2) , (1) , (3) , (4) , (5) , (5) , (6) , (7) , (7) , (7)
1
2
3
4
5
6
7

Abstract

no abstract

Dates and versions

inserm-02530592 , version 1 (03-04-2020)

Identifiers

Cite

Maryline Allegra, Damien Giacchero, Coralie Segalen, Nicolas Dumaz, Catherine Butori, et al.. A New KIT Mutation (N505I) in Acral Melanoma Confers Constitutive Signaling, Favors Tumorigenic Properties, and Is Sensitive to Imatinib. Journal of Investigative Dermatology, 2014, 134 (5), pp.1473-1476. ⟨10.1038/jid.2013.525⟩. ⟨inserm-02530592⟩
33 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More